Rocky Mountain Voice

Menu

Tag: Big Pharma

RFK Jr Launches Major Push To Reduce Antidepressant Overprescribing
No Comments
The Christian Post, Approved, National

RFK Jr Launches Major Push To Reduce Antidepressant Overprescribing

By Jon Brown | The Christian Post Health and Human Services Secretary Robert F. Kennedy Jr. announced a sweeping new initiative earlier this week to reduce what he characterized as the overprescription of antidepressant selective serotonin reuptake inhibitors (SSRIs) and other psychotropic medications, especially for children. "Psychiatric medications have a role in care, but we will no longer treat them as the default," Kennedy said at a Monday summit on mental health and overmedicalization hosted by the Make America Healthy Again (MAHA) Institute in Washington, D.C. "We will treat them as one option, to be used when appropriate, with full transparency and with a clear path off when they are no longer needed." The plan being rolled out by HHS emphasiz...
Read More
From insider to critic: Ex-White House official questions public health orthodoxy
No Comments
All Better, Approved, Commentary, National

From insider to critic: Ex-White House official questions public health orthodoxy

By Katy Talento | AllBetter Substack I kept Robert F. Kennedy Jr. out of the West Wing. Now I owe him an apology. It was 2017. We had hauled the CEOs of a bunch of pharmaceutical companies into the Oval Office so that President Trump could berate them about their drug prices. (Always a good time.) Somehow, the word “vaccine” came up in the conversation. When that happens in the president’s presence, then, now, last month, and probably next week, like clockwork, he always starts telling the same story. A woman who worked for him at the Trump Organization back in the day. Her two-year-old son, who was “perfect, beautiful, magnificent, flawless.” Then he got a shot and he was “just gone. Gone. Never the same. Beautiful boy. Then, just gone.” The CEOs all shrank back and tu...
Read More
Critics Warn Senate Bill 66 Could Limit Affordable Weight Loss Treatments In Colorado
No Comments
Complete Colorado, Approved, Commentary, State

Critics Warn Senate Bill 66 Could Limit Affordable Weight Loss Treatments In Colorado

By: Sherrie Peif | Complete Colorado For decades, Colorado has led the way in legalizing non-FDA approved drugs for use as experimental medicines, including marijuana and other psychedelics. So, I couldn’t believe it when I heard about Senate Bill 26-066, “Regulation of Compounded Weight Loss Medication,” which slaps onerous restrictions on Coloradans’ ability to obtain life-changing, and relatively inexpensive versions of GLP-1 weight loss drugs from compounding pharmacies. A favor to pharma There are so many reasons to oppose this bill, I honestly don’t know how anyone could support the “bi-partisan” effort of Democrat Iman Jodeh and Republican John Carson, other than as a political favor to big pharma. After listening to all the testimony on the bill (as well a...
Read More
Full Steam Ahead on the America First Agenda
No Comments
Rocky Mountain Voice, Commentary, National, Top Stories

Full Steam Ahead on the America First Agenda

By Heidi Ganahl | Commentary, Rocky Mountain Voice A lot of good has already happened in Trump’s first year back. Donald Trump’s first year in the White House has delivered more progress than most presidents manage in an entire term. The border is tightening. Energy is coming back to life. Inflation is easing. America feels steady again. You can see it in people’s faces — a sense of relief, a little pride, a little hope after years of turbulence. But anyone who’s ever built anything knows early wins don’t carry you forever. Momentum is a start, not a finish. We’ve moved things forward, but keeping that ground and pushing it further is the real test. This is where you focus up and just do the work. The America First agenda works — and the next chapter must be about execution, ac...
Read More
RFK Jr. targeted by Pharma’s $2 million lobbying blitz, memo shows
No Comments
National File, Approved, National

RFK Jr. targeted by Pharma’s $2 million lobbying blitz, memo shows

By Ethan Fowler | National File A resurfaced leaked memo from the Biotechnology Innovation Organization (BIO), first revealed by Brownstone Institute, April 2025, details a $2 million campaign to lobby Congress for Robert F. Kennedy Jr.’s removal as HHS Secretary, highlighting Big Pharma’s ongoing desperation amid his MAHA reforms. As Kennedy’s regulatory push intensifies, this old plot—now recirculated by Malone—exposes the industry’s fear of accountability, blending fear-mongering and surrogate influence in a bid to preserve profits over public health. Why it matters: This memo underscores Big Pharma’s corrupt grip on health policy, where billions in vaccine profits clash with Kennedy’s drive for transparency and safety—threatening to unravel a system built on sho...
Read More
Joondeph: Make prescription drugs affordable again
No Comments
American Thinker, Approved, Commentary, National

Joondeph: Make prescription drugs affordable again

By Dr. Brian C. Joondeph | Commentary, American Thinker Last week, President Donald Trump grabbed his Sharpie and signed an executive order to tackle the sky-high prescription drug prices in the U.S. The plan? A “Most Favored Nation” (MFN) pricing model that aligns U.S. drug costs with those of other countries.  Sound familiar? Trump tried this during his first term, but the courts rejected it, and Biden hit the 'undo' button. Here’s the lowdown on why Trump is back at it, what’s at stake, and whether this bold move will stick. Trump has promised cheaper drugs since his campaign days, alongside crowd-pleasers like building the wall and draining the swamp. Americans are fed up, paying nearly three times more for medications than people in other wealthy c...
Read More
Federal judge dismisses drug company’s suit challenging Colorado prescription affordability board
No Comments
Approved, State, The Colorado Sun

Federal judge dismisses drug company’s suit challenging Colorado prescription affordability board

By John Ingold | The Colorado Sun A federal judge tossed out a lawsuit filed by the pharmaceutical company Amgen challenging the authority of a Colorado board that seeks to rein in high-priced prescription drugs. U.S. District Court Judge Nina Y. Wang ruled Friday that Amgen had not shown it has or likely will suffer harm from the board’s actions. As a result, she granted the state’s motion to dismiss the lawsuit, but she did so “without prejudice” — meaning Amgen could sue again if it can later show harm. “The economic injuries alleged by Amgen are too speculative and too attenuated to support standing in this case,” Wang wrote in her order. The case involved a relatively obscure body known as the Colorado Prescription Drug Affordability Board, or PDAB, which has the authority...
Read More
Profit or patients? The 340B fight that could close Colorado hospitals
No Comments
Approved, Rocky Mountain Voice, State, Top Stories

Profit or patients? The 340B fight that could close Colorado hospitals

By Jen Schumann | Contributing Writer, Rocky Mountain Voice If Senate Bill 25-071 fails, Julie Lonborg says her neighbor could end up driving from Lone Tree to Thornton just to pick up a single prescription. That’s not some theoretical what-if. It’s a glimpse into what hospital leaders say is already unfolding in Colorado, especially for patients in rural communities who depend on access to affordable medication through the federal 340B drug discount program. SB25-071, known as the Colorado 340B Contract Pharmacy Protection Act, aims to stop pharmaceutical manufacturers from placing limits on where and how hospitals dispense discounted drugs to vulnerable patients.  Supporters say it’s the only thing standing between local hospitals and a set of restrictions from out-of-state...
Read More
Democrat critics of Robert F. Kennedy Jr. on the big pharma, healthcare dole for millions of dollars
No Comments
Approved, Breitbart, National

Democrat critics of Robert F. Kennedy Jr. on the big pharma, healthcare dole for millions of dollars

By Sean Moran | Breitbart During Robert F. Kennedy Jr.’s confirmation hearing on Wednesday, Senate Democrats criticized the healthcare nominee for chasing money and influence, while they have received millions of dollars from the healthcare industry. Sen. Ron Wyden said that Kennedy, who Trump nominated to be his Health and Human Services Department Secretary, is “someone who chases money and influence wherever they lead, even if that may mean the tragic death of children and other vulnerable people.” Although Wyden attacked Kennedy for allegedly chasing “money and influence,” it appears that Wyden has raised significant sums from the healthcare industry, which has a vested stake in the potential confirmation of Kennedy. READ THE FULL STORY AT BREITBART
Read More
Pharma giant seeks to join lawsuit against FDA over weight loss drugs 
No Comments
Approved, National, THE HILL

Pharma giant seeks to join lawsuit against FDA over weight loss drugs 

By Joseph Choi  | The Hill Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some pharmacies have practiced in mass-marketing copies of its highly popular GLP-1 medications. The lawsuit in question concerns the FDA’s decision to officially declare the shortages of Mounjaro and Zepbound, both forms of the GLP-1 drug tirzepatide, to be over in October. The suit was filed by the Outsourcing Facilities Association (OFA), a trade group that represents 503B compounding pharmacies, seeking to overturn the FDA’s decision. After the suit was filed, the FDA temporarily paused to reconsider the declaration to end the shortage but ultimately reaffirmed its de...
Read More

FD863768-0ACF-495E-9D21-2EF784DFFA6B[1]

Join us at RMV's Freedom Festival

Click Here for Tickets!

This will close in 0 seconds